We thank our sponsors for the kind support of the e:Med Meeting 2022:
LIFE & BRAIN GmbH is a biomedical and neurscientific technology platform founded in 2002 by the University of Bonn and Bonn Medical Center.
LIFE & BRAIN’s mission is to close the gap between academic research and business to develop new strategies for the diagnosis and therapy of nervous system disorders. As an innovation center in the field of biomedicine, LIFE & BRAIN brings together expertise in genomic research, transgenic animals, stem cell biology and neurocognition to deliver novel products for disease modeling, early diagnosis, compound development and tissue regeneration.
Olink Proteomics is a company dedicated to improving the lives of patients by enabling scientists to make breakthrough discoveries in understanding human diseases, with the help of its enabling solutions for protein biomarker research. The Olink platform is widely used across major pharma companies and leading clinical and academic research institutions, providing actionable insights to better understand human biology and drive development of the next generation of therapeutics to improve future healthcare. Olink’s PEA (proximity extension assay) technology continues the long tradition of innovation in protein science generated in Uppsala, Sweden, culminating in the launch of the first 92-protein panel based on PEA in 2013. The technology now enables high-throughput measurement of >3000 proteins simultaneously with exceptional data quality. The company was founded in 2016 and is well established across Europe, North America and Asia.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB™ short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio. PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
The National Institute for Science Communication (NaWik) is a non‐profit organisation, established in 2012. NaWik stakeholders are the Klaus Tschira Foundation and the Karlsruhe Institute of Technology, KIT.
Science is an important part of our culture and scientific findings influence the future development of society. The vision of NaWik is to improve the information flow from academic research to the public with the goal of a more scientifically literate society.
NaWik trains scientists to communicate their intentions, findings and issues to a wider audience and engage with society for a dialog. For that purpose, NaWik offers a portfolio of on-site and online seminars and maintains an e-learning platform (www.nawik.de).
NaWik fosters the exchange between communicating scientists on its WissKon network (www.nawik.de/wisskon - currently only available in German), performs in-house science communication research and is a founding partner of the platform wissenschaftskommunikation.de.
In recent years, ever-increasing applications of omics technologies have revolutionized life science and simultaneously created the need to store, process, and analyze large amounts of data. To meet these challenges, the German Network for Bioinformatics Infrastructure (de.NBI) has been established as a distributed bioinformatics network since 2015, initially funded by the German Ministry of Education and Research (BMBF). From 2022 onwards, the network is continued by the Forschungszentrum Jülich, a member of the Helmholtz association. The transition process is ongoing.
The network consists of eight Service Centers comprising 40 project partners located throughout Germany. It serves the life science research community by offering bioinformatic tools, training, compute resources, as well as connection to major industrial companies within Germany and Europe. The tool portfolio consists of over 100 services and tools ranging from databases and stand-alone tools to complete workflows for the processing and analysis of omics data. In the area of training, de.NBI offers tailor-made training courses, webinars, and online courses on omics tools or workflows which enable researchers to turn their raw data into tangible results. Approximately, 80 training courses per year are offered to researchers and users on national and international level. In the last seven years, the de.NBI network has trained more than 9.000 life scientists at all qualification levels. The network also offers large computing power and storage capacities of the federated de.NBI Cloud that allows researchers to process and analyze their own data.
With its wide range of bioinformatics expertise and reputable partner institutions, the de.NBI network guarantees the delivery of high-standard bioinformatics services, comprehensive training, as well as powerful computing capacities that contribute to the advancement of life science research in Germany and Europe.
Genomic data from patients are of great value for biomedical research, and increasingly also for diagnostics and personalized therapies. Extensively characterized data sets are currently generated across Germany. Integration of these local data sets is essential for their optimal use. Modern computer services such as machine learning or artificial intelligence, for example, only unfold their full potential with access to combined big data.
The need to make data open and FAIR for the research community must always be weighed against the protection of the patient's privacy. To balance data protection and data usage, GHGA (German Human Genome-Phenome Archive) is building a national infrastructure for human genome data. This will allow highly sensitive genome data to be merged, saved and analyzed in a uniform, data protection-compliant framework.
GHGA is funded, alongside eight other consortia, as part of the German national program for research data infrastructures - the NFDI e.V. - by the DFG. As a national node of the federated European Genome Phenome Archive (EGA), GHGA can follow national regulations on data protection and at the same time be closely linked to international data infrastructures. Coordinated via the German Cancer Research Center (DKFZ), GHGA has 46 participants from 21 institutions.